המרכז הרפואי כרמל, על שם ליידי דייויס, הוא בית חולים הממוקם בשכונת אחוזה בחיפה ומשתייך לשירותי בריאות כללית.

During the past decade, Carmel Medical Center conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 40 clinical trials were completed, i.e. on average, 30.3% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 32 clinical trials were completed. i.e. 50.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carmel Medical Center" #1 sponsor was "Carmel Medical Center" with 61 trials, followed by "Janssen Research & Development, LLC" with 20 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Actelion" with 7 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carmel Medical Center" #1 collaborator was "Technion, Israel Institute of Technology" with 7 trials as a collaborator, "Carmel Medical Center" with 5 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Rambam Health Care Campus" with 3 trials as a collaborator and "Tel-Aviv Sourasky Medical Center" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Carmel Medical Center" are "Pulmonary Arterial Hypertension" (5 trials), "Cystic Fibrosis" (4 trials), "Hepatitis C, Chronic" (4 trials), "Multiple Myeloma" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Carmel Medical Center" in a lesser frequency.

Most popular intervention types in "Carmel Medical Center" are "Drug" (98 trials), "Device" (32 trials), "Other" (28 trials), "Procedure" (10 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Daratumumab" (6 trials), "Dexamethasone" (5 trials), "Baricitinib" (4 trials) and "Bortezomib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Carmel Medical Center" are 185 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 59 active trials in "Carmel Medical Center". 1 are not yet recruiting, 37 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in Carmel Medical Center, 2 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Carmel Medical Center, 9 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 39 trials that are defined as “Not Applicable".